10Y UST5.24%+1.35%30Y MTG7.03%+1.15%SOFR3.88%-0.51%VNQ$90.12-0.45%XLRE$41.13-0.50%FED FUNDS3.88%
Real Estate Trail
Institutional Press Wire
CommercialSearch · Land

BioMed to Land $915M for Life Science Asset

Via CommercialSearch · September 30, 2026
Compiled by Real Estate Trail Editorial · September 30, 2026

Why this matters

Land continues to behave as the highest-conviction long-duration bet in CRE. In supply-constrained luxury markets, replacement-cost-positive entitlements remain scarce; in growth-corridor exurbs, sponsors with patient capital are accumulating positions ahead of the next residential or industrial pipeline. The trade is a basis call, not an income call, and continues to attract family-office and high-net-worth capital that can hold through the cycle.

Editorial analysis · Real Estate Trail Editorial

On the RET wire

  • Disclosed land deal value tracked in September 2026: $468.5M across 4 reported transactions. All Land coverage →

Computed from Real Estate Trail’s own tracked coverage

Read the full article at CommercialSearch →

External link. Real Estate Trail does not republish source content.

Related coverage — Land

More from the wire